Mesabi Trust (MSB)
(Delayed Data from NYSE)
$29.35 USD
-0.55 (-1.84%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $29.39 +0.04 (0.14%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MSB 29.35 -0.55(-1.84%)
Will MSB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MSB based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MSB
Mesoblast’s U.S. Origin Cell Therapies Exempt from Tariffs
Largest borrow rate increases among liquid names
50 Day Moving Average Resistance appears for MSB after 0.53% move
Is MSB likely to continue lower? Fell Below 50 Day Moving Average shows up after dropping 2.69%
State Street Corporation Ceases Substantial Holding in Mesoblast Limited